Syncona Limited Issue of shares pursuant to the Long Term Incentive Plan

 
TIDMSYNC 
 
Syncona Limited 
 
           Issue of shares pursuant to the Long Term Incentive Plan 
 
13 August 2018 
 
Syncona Limited (the "Company") today announces that a total of 20,836 new 
ordinary shares will be issued in satisfaction of realisations under the 
Company's Long Term Incentive Plan.  The new ordinary shares, when issued, will 
rank pari passu with the existing issued ordinary shares of the Company. 
 
In accordance with the rules of the Long Term Incentive Plan, ordinary shares 
delivered on realisation may not be sold or transferred by the recipient for a 
period of one year following the realisation date. 
 
Application has been made to the Financial Conduct Authority for the shares to 
be admitted to the Official List, and to the London Stock Exchange for the 
shares to be admitted to trading and it is expected that dealings will commence 
in the new ordinary shares on 16 August 2018. 
 
[ENDS] 
 
Enquiries 
 
Syncona Ltd 
Annabel Clay 
Tel: [phone] 
 
Northern Trust International Fund Administration Services (Guernsey) Limited 
Company Secretary 
Tel: [phone] 
 
Copies of this press release and other corporate information can be found on 
the company website at: www.synconaltd.com 
 
About Syncona: 
 
Syncona is a leading FTSE250 healthcare company focused on investing in and 
building global leaders in life science. Our vision is to deliver 
transformational treatments to patients in truly innovative areas of healthcare 
while generating superior returns for shareholders. 
 
We seek to partner with the best, brightest and most ambitious minds in science 
to build globally competitive businesses. 
 
We take a long-term view, underpinned by a deep pool of capital, and are 
established leaders in gene and cell therapy. We focus on delivering dramatic 
efficacy for patients in areas of high unmet need. 
 
 
 
END 
 

(END) Dow Jones Newswires

August 13, 2018 07:39 ET (11:39 GMT)